Clariant: Deutsche Bank raises target price
(CercleFinance.com) - Deutsche Bank announced on Friday that it had raised its target price for Clariant from 13.
5 CHF to 15 CHF, ahead of the publication of the Swiss specialty chemicals group's Q2 results on 30 July.
The analyst expects adjusted operating profit (Ebitda) to rise by 31.5% y-o-y, to 184m CHF, against a consensus of 167m CHF.
The broker explains that it expects improved performance in skin care products, absorbers and additives, which he believes should more than offset weakness in catalysts.
DB also believes that it is not impossible for the Swiss chemical company to raise its annual targets, pointing out that it is currently targeting a 1% to 3% increase in sales in local currencies this year, with an EBITDA margin of 15%.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
5 CHF to 15 CHF, ahead of the publication of the Swiss specialty chemicals group's Q2 results on 30 July.
The analyst expects adjusted operating profit (Ebitda) to rise by 31.5% y-o-y, to 184m CHF, against a consensus of 167m CHF.
The broker explains that it expects improved performance in skin care products, absorbers and additives, which he believes should more than offset weakness in catalysts.
DB also believes that it is not impossible for the Swiss chemical company to raise its annual targets, pointing out that it is currently targeting a 1% to 3% increase in sales in local currencies this year, with an EBITDA margin of 15%.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as decision-making aids for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.